These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 32995093)
1. Galectin-3 not Galectin-9 as a candidate prognosis marker for hepatocellular carcinoma. Kong F; Jin M; Cao D; Jia Z; Liu Y; Jiang J PeerJ; 2020; 8():e9949. PubMed ID: 32995093 [TBL] [Abstract][Full Text] [Related]
2. Overexpression of Galectin-1 and Galectin-3 in hepatocellular carcinoma. Setayesh T; Colquhoun SD; Wan YY Liver Res; 2020 Dec; 4(4):173-179. PubMed ID: 34567824 [TBL] [Abstract][Full Text] [Related]
3. Galectin-9 expression predicts poor prognosis in hepatitis B virus-associated hepatocellular carcinoma. Jiao J; Jiao D; Yang F; Zhang J; Li Y; Han D; Zhang K; Wang Y; Zhang R; Yang AG; Wang A; Wen W; Qin W Aging (Albany NY); 2022 Feb; 14(4):1879-1890. PubMed ID: 35202002 [TBL] [Abstract][Full Text] [Related]
4. Galectin-9 Expression Predicts Favorable Clinical Outcome in Solid Tumors: A Systematic Review and Meta-Analysis. Zhou X; Sun L; Jing D; Xu G; Zhang J; Lin L; Zhao J; Yao Z; Lin H Front Physiol; 2018; 9():452. PubMed ID: 29765332 [No Abstract] [Full Text] [Related]
5. Decreased galectin-9 and increased Tim-3 expression are related to poor prognosis in gastric cancer. Jiang J; Jin MS; Kong F; Cao D; Ma HX; Jia Z; Wang YP; Suo J; Cao X PLoS One; 2013; 8(12):e81799. PubMed ID: 24339967 [TBL] [Abstract][Full Text] [Related]
6. Galectin-1 promotes hepatocellular carcinoma and the combined therapeutic effect of OTX008 galectin-1 inhibitor and sorafenib in tumor cells. Leung Z; Ko FCF; Tey SK; Kwong EML; Mao X; Liu BHM; Ma APY; Fung YME; Che CM; Wong DKH; Lai CL; Ng IO; Yam JWP J Exp Clin Cancer Res; 2019 Oct; 38(1):423. PubMed ID: 31640796 [TBL] [Abstract][Full Text] [Related]
7. Galectin-3 is associated with a poor prognosis in primary hepatocellular carcinoma. Jiang SS; Weng DS; Wang QJ; Pan K; Zhang YJ; Li YQ; Li JJ; Zhao JJ; He J; Lv L; Pan QZ; Xia JC J Transl Med; 2014 Sep; 12():273. PubMed ID: 25260879 [TBL] [Abstract][Full Text] [Related]
8. Expression of galectin-3 involved in prognosis of patients with hepatocellular carcinoma. Matsuda Y; Yamagiwa Y; Fukushima K; Ueno Y; Shimosegawa T Hepatol Res; 2008; 38(11):1098-111. PubMed ID: 18684128 [TBL] [Abstract][Full Text] [Related]
9. Galectin-9 predicts postoperative recurrence and survival of patients with clear-cell renal cell carcinoma. Fu H; Liu Y; Xu L; Liu W; Fu Q; Liu H; Zhang W; Xu J Tumour Biol; 2015 Aug; 36(8):5791-9. PubMed ID: 25716202 [TBL] [Abstract][Full Text] [Related]
10. Association between high galectin expression and poor prognosis in hematologic cancers: a systematic review and meta-analysis. Liu H; Dai Q; Li Y; Tang Z; She T Hematology; 2023 Dec; 28(1):2227494. PubMed ID: 37343172 [TBL] [Abstract][Full Text] [Related]
11. Prognostic value of tumoral expression of galectin-9 in gastric cancer. Choi SI; Seo KW; Kook MC; Kim CG; Kim YW; Cho SJ Turk J Gastroenterol; 2017 May; 28(3):166-170. PubMed ID: 28492371 [TBL] [Abstract][Full Text] [Related]
12. Over expression of galectin-3 associates with short-term poor prognosis in stage II colon cancer. Huang Z; Ai Z; Li N; Xi H; Gao X; Wang F; Tan X; Liu H Cancer Biomark; 2016; 17(4):445-455. PubMed ID: 28085015 [TBL] [Abstract][Full Text] [Related]
13. Role of Galectins in the Liver Diseases: A Systematic Review and Meta-Analysis. An Y; Xu S; Liu Y; Xu X; Philips CA; Chen J; Méndez-Sánchez N; Guo X; Qi X Front Med (Lausanne); 2021; 8():744518. PubMed ID: 34778306 [No Abstract] [Full Text] [Related]
14. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis. Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703 [TBL] [Abstract][Full Text] [Related]
15. [Expression and prognostic value of galectin-9 in hepatocellular carcinoma patients]. Gu CJ; Wu H; Sheng CY; Ni QC Zhonghua Yi Xue Za Zhi; 2013 Jul; 93(26):2025-8. PubMed ID: 24169278 [TBL] [Abstract][Full Text] [Related]
16. Galectin-1 and galectin-3: plausible tumour markers for oral squamous cell carcinoma and suitable targets for screening high-risk population. Aggarwal S; Sharma SC; Das SN Clin Chim Acta; 2015 Mar; 442():13-21. PubMed ID: 25578395 [TBL] [Abstract][Full Text] [Related]
17. Clinical relevance of galectin-1 expression in non-small cell lung cancer patients. Carlini MJ; Roitman P; Nuñez M; Pallotta MG; Boggio G; Smith D; Salatino M; Joffé ED; Rabinovich GA; Puricelli LI Lung Cancer; 2014 Apr; 84(1):73-8. PubMed ID: 24560493 [TBL] [Abstract][Full Text] [Related]
18. Prognostic value of galectin-1 and galectin-3 expression in localized urothelial bladder cancer. Zhu J; Livasy C; Donahue EE; Symanowski JT; Grigg CM; Brown LC; Matulay JT; Kearns JT; Raghavan D; Burgess EF; Clark PE Transl Androl Urol; 2023 Feb; 12(2):228-240. PubMed ID: 36915891 [TBL] [Abstract][Full Text] [Related]
19. Overexpression of galectin-1 is associated with poor prognosis in human hepatocellular carcinoma following resection. Wu H; Chen P; Liao R; Li YW; Yi Y; Wang JX; Sun TW; Zhou J; Shi YH; Yang XR; Jin JJ; Cheng YF; Fan J; Qiu SJ J Gastroenterol Hepatol; 2012 Aug; 27(8):1312-9. PubMed ID: 22432916 [TBL] [Abstract][Full Text] [Related]
20. Galectin-8 and -9 as prognostic factors for cervical cancer. Beyer S; Wehrmann M; Meister S; Kolben TM; Trillsch F; Burges A; Czogalla B; Schmoeckel E; Mahner S; Jeschke U; Kolben T Arch Gynecol Obstet; 2022 Oct; 306(4):1211-1220. PubMed ID: 35377045 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]